Transcriptomics

Dataset Information

0

F. nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer


ABSTRACT: At present, the mechanisms underlying the association between gut microbiota metabolites and immunotherapy in CRC remain unknown. Here, we conducted a multiomics analysis of a cohort of patients with mCRC and found that F.nucleatum was more abundant in patients who did not respond to immunotherapy. We also found that F. nucleatum diminished the sensitivity to anti-PD-1 mAb through its metabolite succinic acid. Accordingly, patients with lower serum succinic acid levels achieved a better response to immunotherapy. Mechanistically, F.nucleatum-derived succinic acid suppressed the cGAS-interferon-β pathway, consequently dampening the antitumor response by limiting CD8+ T-cell trafficking to the tumor microenvironment in vivo. Treatment with metronidazole reduced intestinal F.nucleatum abundance and thereby decreased serum succinic acid levels, thus resensitizing the tumors to immunotherapy in vivo. Collectively, our findings indicate that F. nucleatum and its metabolite succinic acid induce tumor resistance to immunotherapy and offer new insights into microbiota-metabolite-immune crosstalk in CRC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE181337 | GEO | 2023/10/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-12-01 | GSE209864 | GEO
| PRJNA862743 | ENA
| PRJNA751598 | ENA
| PRJNA750659 | ENA
2022-08-21 | GSE192400 | GEO
2009-10-29 | E-GEOD-17991 | biostudies-arrayexpress
2024-08-17 | GSE241076 | GEO
2022-01-09 | GSE193190 | GEO
2021-10-19 | GSE173549 | GEO
2024-07-10 | PXD053279 | Pride